{"data":{"type":"company_profile_ai","id":83991,"entity_id":"wefunder:company:83991","attributes":{"canonical_url":"https://wefunder.com/entelexo","retrieval_urls":{"canonical":"https://wefunder.com/entelexo","json":"https://wefunder.com/entelexo.json","markdown":"https://wefunder.com/entelexo.md","ai_json":"https://wefunder.com/entelexo.ai.json","ai_text":"https://wefunder.com/entelexo.ai.txt","changelog_json":"https://wefunder.com/entelexo.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-06-22T05:03:19Z","generated_at":"2026-06-23T00:56:00Z","profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":true,"privacy_mode":"promote","invite_only":false},"company":{"id":83991,"entity_id":"wefunder:company:83991","slug":"entelexo","name":"Entelexo (YC W21)","tagline":"Creating a new class of drugs to address incurable autoimmune diseases","elevator_pitch":"We are applying new knowledge of stem cell biology to develop new treatments for autoimmune diseases.","location":"Irvine, CA","website":"https://www.entelexo.com/","total_amount_raised":32890,"total_investors":80,"is_funded":true,"is_active":true},"key_claims":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 32890","citation":"https://wefunder.com/entelexo#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-22T05:03:19Z","as_of":"2026-06-23T00:56:00Z","confidence":"high"},"observed_at":"2026-06-22T05:03:19Z","expires_at":"2026-06-23T05:03:19Z"},{"claim_id":"claim-total-investors","text":"Total investors: 80","citation":"https://wefunder.com/entelexo#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-22T05:03:19Z","as_of":"2026-06-23T00:56:00Z","confidence":"high"},"observed_at":"2026-06-22T05:03:19Z","expires_at":"2026-06-23T05:03:19Z"}],"verified_facts":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 32890","citation":"https://wefunder.com/entelexo#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-22T05:03:19Z","as_of":"2026-06-23T00:56:00Z","confidence":"high"},"observed_at":"2026-06-22T05:03:19Z","expires_at":"2026-06-23T05:03:19Z"},{"claim_id":"claim-total-investors","text":"Total investors: 80","citation":"https://wefunder.com/entelexo#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-22T05:03:19Z","as_of":"2026-06-23T00:56:00Z","confidence":"high"},"observed_at":"2026-06-22T05:03:19Z","expires_at":"2026-06-23T05:03:19Z"}],"company_claims":{"tagline":"Creating a new class of drugs to address incurable autoimmune diseases","elevator_pitch":"We are applying new knowledge of stem cell biology to develop new treatments for autoimmune diseases.","quick_facts":["\u0026gt;$1M raised to date, plus $310k on the same terms","CEO led the 1st clinical trials in the world evaluating exosomes as a treatment for autoimmune disease","Targeting 25M affected by immune-mediated diseases in US, equal to ~$150B in medical costs/year","Our intellectual property is patent-protected (patent owned by the Company)","Raising $2M for pre-clinical product development and IND enabling animal studies"]},"computed_metrics":{"total_amount_raised":32890,"total_investors":80,"team_size":3,"featured_investor_count":1,"faq_count":0,"recent_post_count":0},"quick_facts":[{"claim_id":"claim-fact-1","value":"\u0026gt;$1M raised to date, plus $310k on the same terms","citation":"https://wefunder.com/entelexo#claim-fact-1","observed_at":"2026-06-22T05:03:19Z","expires_at":"2026-06-29T05:03:19Z"},{"claim_id":"claim-fact-2","value":"CEO led the 1st clinical trials in the world evaluating exosomes as a treatment for autoimmune disease","citation":"https://wefunder.com/entelexo#claim-fact-2","observed_at":"2026-06-22T05:03:19Z","expires_at":"2026-06-29T05:03:19Z"},{"claim_id":"claim-fact-3","value":"Targeting 25M affected by immune-mediated diseases in US, equal to ~$150B in medical costs/year","citation":"https://wefunder.com/entelexo#claim-fact-3","observed_at":"2026-06-22T05:03:19Z","expires_at":"2026-06-29T05:03:19Z"},{"claim_id":"claim-fact-4","value":"Our intellectual property is patent-protected (patent owned by the Company)","citation":"https://wefunder.com/entelexo#claim-fact-4","observed_at":"2026-06-22T05:03:19Z","expires_at":"2026-06-29T05:03:19Z"},{"claim_id":"claim-fact-5","value":"Raising $2M for pre-clinical product development and IND enabling animal studies","citation":"https://wefunder.com/entelexo#claim-fact-5","observed_at":"2026-06-22T05:03:19Z","expires_at":"2026-06-29T05:03:19Z"}],"latest_fundraise":{"id":44491,"entity_id":"wefunder:fundraise:44491","state":"successful","offering_type":"4(a)(6)","structure":"safe","testing_the_waters":false,"can_invest_now":false,"funding_started_at":"2021-06-24T10:30:02Z","funding_closed_at":"2021-07-28T05:04:33Z"},"investor_memos":[],"team":[{"id":1621013,"entity_id":"wefunder:company_role:1621013","name":"Milad Riazifar","title":"CEO","role":"founder","profile_url":"https://wefunder.com/milad.riazifar"},{"id":1621017,"entity_id":"wefunder:company_role:1621017","name":"Todd Schurr","title":"COO","role":"founder","profile_url":"https://wefunder.com/toddschurr"},{"id":1629893,"entity_id":"wefunder:company_role:1629893","name":"Cameron Taylor","title":"CTO","role":"founder","profile_url":"https://wefunder.com/camerontaylor3"}],"featured_investors":[{"id":5276,"entity_id":"wefunder:company_investor_profile:5276","name":"Nate Lipscomb","bio":"Investor in mission-driven early stage startups, including Juni Learning, Orbillion Bio, NewZip, Caribou Biosciences, Recover, and AN2 Therapeutics.","profile_url":"https://wefunder.com/nate.lipscomb"}],"relationships":[{"source_entity_id":"wefunder:company:83991","relation":"has_team_member","target_entity_id":"wefunder:user:1447331","target_url":"https://wefunder.com/milad.riazifar"},{"source_entity_id":"wefunder:company:83991","relation":"has_team_member","target_entity_id":"wefunder:user:1409148","target_url":"https://wefunder.com/toddschurr"},{"source_entity_id":"wefunder:company:83991","relation":"has_team_member","target_entity_id":"wefunder:user:1409240","target_url":"https://wefunder.com/camerontaylor3"},{"source_entity_id":"wefunder:company:83991","relation":"has_featured_investor","target_entity_id":"wefunder:user:12801","target_url":"https://wefunder.com/nate.lipscomb"},{"source_entity_id":"wefunder:company:83991","relation":"has_latest_fundraise","target_entity_id":"wefunder:fundraise:44491"}],"faq":[],"recent_posts":[],"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-06-23T00:56:00Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-22T05:03:19Z","as_of":"2026-06-23T00:56:00Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-22T05:03:19Z","as_of":"2026-06-23T00:56:00Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2025-02-06T01:17:55Z","as_of":"2026-06-23T00:56:00Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2025-02-06T01:17:55Z","as_of":"2026-06-23T00:56:00Z","confidence":"medium"}}}}}}